Agathe is a neurologist and a researcher at the Cognitive Neurology Center, Lariboisière University Hospital, France.
Words of Strength
Collaboration drives research forward
To reduce the scale and impact of dementia, we need to generalize access to early and reliable diagnosis. As the first disease-modifying therapies are starting to be accessible, we need to diagnose patients in an accurate time window.
Agathe works as neurologist to provide clinical care and access to therapeutic trials to patients with dementia. Her research work explores novel fluid biomarkers for diagnosis, prognosis and which could help understanding underlying mechanisms.
Agathe aims to contribute to the validation of novel, cost-effective and non-invasive diagnosis biomarkers through large collaborative projects with the GBHI community. Those markers could improve access to early intervention and prevention measures.
By bringing new diagnosis tools for dementia in clinical settings, Agathe goal is to provide timely diagnosis and care to dementia patients from all communities and backgrounds.
Agathe Vrillon received her MD and completed her neurological residency at Université Paris Descartes, Paris, France. She trained in biochemistry between Université Paris Cité, France and Gothenburg University, Sweden and received her PhD in 2022.